NUTRACEUTICAL INTERNATIONAL CORP Finite-Lived Intangible Asset, Expected Amortization, Year Two

NUTRACEUTICAL INTERNATIONAL CORP had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $5.27 million as of 2017-06-30, per its 10-Q filed 2017-07-27.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2017-07-27

2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $5.27M.
2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $3.42M.
2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $3.41M.
2016-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $3.41M.

Period end	Finite-Lived Intangible Asset, Expected Amortization, Year Two
2017-06-30	$5.27M 10-Q · filed 2017-07-27
2017-03-31	$3.42M 10-Q · filed 2017-04-27
2016-12-31	$3.41M 10-Q · filed 2017-01-26
2016-09-30	$3.41M 10-K · filed 2016-11-17
2016-06-30	$3.59M 10-Q · filed 2016-07-28
2016-03-31	$3.58M 10-Q · filed 2016-04-28
2015-12-31	$3.51M 10-Q · filed 2016-01-28
2015-09-30	$2.56M 10-K · filed 2015-11-19
2015-06-30	$2.23M 10-Q · filed 2015-07-30
2015-03-31	$2.17M 10-Q · filed 2015-04-30
2014-12-31	$2.16M 10-Q · filed 2015-01-29
2014-09-30	$2.16M 10-K · filed 2014-11-20
2014-06-30	$2.78M 10-Q · filed 2014-07-31
2014-03-31	$2.41M 10-Q · filed 2014-04-24
2013-12-31	$2.29M 10-Q · filed 2014-01-30
2013-09-30	$1.93M 10-K · filed 2013-11-26
2013-06-30	$1.89M 10-Q · filed 2013-07-25
2013-03-31	$1.84M 10-Q · filed 2013-04-25
2012-12-31	$1.83M 10-Q · filed 2013-01-31
2012-09-30	$1.83M 10-K · filed 2012-11-21
2012-06-30	$2.11M 10-Q · filed 2012-07-26